PAHO 2001 1 Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.

Slides:



Advertisements
Similar presentations
Contribution of the Americas to the WCDR Inter American Committee for Natural Disaster Reduction OAS, PAHO/WHO, IDB, IICA, …
Advertisements

Presentation to the Executive Committee PAHO/WHO, June 2003 West Nile Virus (WNV) in Latin America and the Caribbean PAHO Communicable Disease Unit.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Module 4: Final Case Study # 4-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 4-CS-2.
Combatting Antimicrobial Drug Resistance Dr Charles Penn Pandemic and Epidemic Diseases Health Security and Environment.
Role of the laboratory in disease surveillance
TRAINING FOR ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN HOSPITALS JUNE 2014.
Antimicrobial Resistance Surveillance Latin America
Antibiotic Policy in Ghana; the way forward
Lesson 3 Good Production Practice #3 Use Antibiotics Responsibly.
 Evaluation of Surveillance Systems St Lukes-Roosevelt.
TBS November 4, |1 | AMR and appropriate use of antimicrobials Nicola Magrini and Jane Robertson Policy, Access and Use Team, EMP TBS 4 November.
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
WHO local pilot projects to contain AMR ICIUM 2004 K.A.Holloway and T.L.Sorensen Essential Drugs and Medicines Policy WHO Geneva.
WHO COLLABORATION | September 13, | WHO Indonesia Collaboration with Animal Health.
Pan American Health Organization 44th Directing Council, September Integrated Strategy for Dengue Prevention and Control.
The Antibiotic Sensitivity Test Presented by Marian Mikhail Undergraduate student Biology Major Health and Science Concentration Health and Science Concentration.
Infection Control Clinical Pharmacy and Patient Safety
Surveillance Systems: Their Role in Identifying Risk and Resilience Factors Diego E Zavala, M.Sc., Ph.D. Associate Professor Public Health Program, Ponce.
Ecdc.europa.eu Tommi Asikainen, Tubingen, 22 October 2008 European Centre for Disease Prevention and Control FUTURE DISEASE CHALLENGES IN EUROPE – where.
Problem Statement: In Kenya, despite the development of national standard treatment guidelines (STGs) for the management of acute respiratory infections.
LAC REGIONAL PHN PROGRAMS. HEALTH PRIORITIES Strategic Objective  More effective delivery of selected health services and policy interventions.
Infectious Disease Epidemiology Surveillance. 9/22/00ANN JOLLY 2 Definition n “Ongoing systematic collection, analysis, and interpretation of health data.
Promoting Drug and Therapeutics Committees in the Developing World
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Unit 6: Specialised Techniques: Anti-Microbial Resistance Monitoring and Assessment of STI Syndrome Aetiologies #4-6-1.
MLAB Microbiology Keri Brophy-Martinez Public Health & The Microbiology Lab.
Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.
PSA: Drugs, Antibiotics, & Pesticides Resistance By Haley Cole, Katelyn Le-Thompson, & Amanda Lucas.
An Intervention To Improve Antibiotic Prescribing Habits of Doctors in a Teaching Hospital Ofei F, Forson A, Tetteh R, Ofori-Adjei D University of Ghana.
1 Vision: To be an agency producing outputs that contribute to optimal efficiency of the Indonesian Universal Health Coverage (UHC) Mission: To ensure.
Holy Family Catholic High School 17th April 2007 Developing medicines + Immunity UNIT 11.4 Controlling infectious disease Form 10 A4.
Country report for “Peste des Petits Ruminants(PPR).” Dr. Yousef S N S SH Al Azemi Head, Epidemiology & Zoonosis, Animal Health Department Public Authority.
Perspectives on containing antimicrobial resistance – ways to go … Karl Ekdahl, Strategic Advisor on behalf of Zsuzsanna Jakab, Director European Centre.
ASDPE Regional Plan for Strengthening the National Influenza Surveillance Capacity: Guiding the way towards a comprehensive National Influenza Surveillance.
Objective General Objective: To review the implementation of PIDSR in CALABARZON and to what extent the surveillance goals are achieved.
Introduction to NCHS Rob Weinzimer, Special Assistant for Outreach Centers for Disease Control and Prevention National Center for Health Statistics.
The role of PHE’s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit © Crown.
Lesson 3 Page 1 of 24 Lesson 3 Considerations in Planning Public Health Surveillance.
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
Antimicrobial Stewardship
Ch Epidemiology Microbiology.
Antibiotic Policy in Ghana; the way forward
Title of the Change Project
Promoting Drug and Therapeutics Committees in the Developing World
Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Sripairoj A, Liamputtong P, Harvey K La Trobe University, Australia.
Gender Statistics at the United States Census Bureau
Professor Alan Johnson Department of HCAI & AMR
Quality Assurance and Safety of Medicines
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Call topic identification for 2019 call
Antimicrobial Resistance: Plans for Korea and Beyond
Cedric Lazarus Livestock Development Officer
Do Khang Chien, MD, PhD Nguyen Thi Phuong Cham,BSPh
Vision, Mission, and Goals
“An overview” 10th April 2018 at MOH SMT Now 27th April 2018 at NPHIL
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
Introduction to public health surveillance
D.E. Low  Clinical Microbiology and Infection 
Essential Drugs and Medicines Policy
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
Essential Drugs and Medicines Policy
Antibiotic Resistance
Evaluating International Drug and Therapeutics Committees Courses in the Developing World
Use Antibiotics Responsibly
Anti-microbial resistance
Sweden I 2006 National strategy
Presentation transcript:

PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization

PAHO What is Antimicrobial Resistance? The ability of bacteria and other microorganisms to survive an antibiotic to which they were once sensitive (and were once stalled or killed completely)

PAHO Mechanism of resistance Natural or intrinsic resistance Acquired resistance –Chromosomal mutation –Transfer of genetic material

PAHO Contributing Factors Human medicine Animal medicine Agriculture

PAHO

6 Implications of Antimicrobial Resistance CLINICAL Morbidity Mortality COST LIMITED SOLUTIONS

PAHO SURVEILLANCE Surveillance is the ongoing systematic collection, analysis, interpretation and dissemination of the health data to those persons who have the responsibility for disease prevention and control

PAHO Characteristics Quality data Timely Enables comparison Linked to policy and clinical practice

PAHO Use of Surveillance Estimate the magnitude of a health problem problem

PAHO Percentage of S. pneumonie Resistant to penicillin, American Region 1993/

PAHO Use of Surveillance Epidemic detection

PAHO NICARAGUA, Vibrio cholerae: Antibiotic susceptibility

PAHO Use of Surveillance Follow trends and patterns of antimicrobial resistance

PAHO

PAHO Percentage of Shigella spp. isolates resistant to different antibiotics. Peru,

PAHO Percentage of Shigella flexneri isolates resistant to different antibiotics. Ecuador,

PAHO Use of Surveillance Determine geographical distribution and spread of antimicrobial resistance

PAHO

PAHO Goal To preserve the effectiveness of currently available antimicrobial drugs Improve the availability of drugs of assured quality Ensure appropriate use of drugs when they are required Decrease use of drugs when they are not required

PAHO Approaches to address AMR Health System strengthening Policy and regulation Provider and consumer behavior

PAHO Antimicrobial Resistance Surveillance Program IN 1996, PAHO’s DIRECTING BODIES RECOMMENDED THAT THE ORGANIZATION PUT IN PLACE AN ANTIMICROBIAL RESISTANCE SURVEILLANCE PROGRAM

PAHO Participating Countries } Caribbean Countries Countries starting in 1996 Countries incorporated w/ USAID project

PAHO A network of national reference laboratories was established A database set for the American Region was created A web page in PAHO web site was created Results

PAHO Results Protocol for quality assurance and proficiency testing for antibiotic susceptibility Workshops to provide training in bacterial identification and testing for antimicrobial resistance were implemented Protocol for assessing the cost of hospital infections and selected antimicrobial resistance were developed and implemented

PAHO Results TOT on rational use of antimicrobial drugs Training material Drugs therapeutics committees Regional treatment guidelines

PAHO Results Different materials on antimicrobial resistance were produced and distributed References on antimicrobial resistance were compiled into a bibliography, which will be published in a month